Tailored Solutions for the Unique Challenges of Oncology Trials
Engagement with a range of experts is essential when designing oncology trials, where the complexity of trial design surpasses the expertise of any single individual.
In the latest Pharma’s Almanac article, Colin Hayward, MB BS, Head of Medical Science for Ergomed Clinical Research provides insights into critical components of effective oncology trial design.

Key highlights:
- Engagement with advocacy groups for patient-centered insights
- Effective collaboration between study sponsors and seasoned CROs
- Careful selection of investigator sites
- Ergomed’s distinctive advantages in advancing oncology trials
Unlock these insights in, “Navigating the Complex Landscape of Oncology Trials.”
"*" indicates required fields